Form 4: PineBridge GEM II G.P., L.P. Sells IBEX Ltd Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
PineBridge GEM II G.P., L.P., along with related entities and individuals, sold 60,000 shares of IBEX Ltd (IBEX) between September 23 and September 25, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- PineBridge GEM II G.P., L.P., and related parties, including John Leone, Kevin Clowe, and Pierre Mellinger, filed a Form 4 detailing changes in beneficial ownership of IBEX Ltd shares.
- The transactions involved the sale of 60,000 common shares of IBEX Ltd over three days: September 23, 24 and 25, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on June 14, 2024.
- The shares were sold at weighted average prices ranging from $19.8231 to $20.0018 on the respective days.
- Following the reported transactions, PineBridge Global Emerging Markets Partners II, L.P. indirectly holds 1,864,739 shares.
- The reporting persons disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports share sales under a pre-arranged trading plan, with no indication of positive or negative outlook.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders or significant shareholders of a publicly traded company buy or sell shares; this filing indicates activity by a major shareholder of IBEX Ltd.
Stakeholder Impact
- The share sales by a significant shareholder could potentially create short-term price volatility for shareholders.
- The sales may have a minor impact on market perception of the company.
Key Dates
| Date | Description |
|---|---|
| 2024-06-14 | Date of adoption of the Rule 10b5-1 trading plan by PineBridge Global Emerging Markets Partners II, L.P. |
| 2024-09-23 | Date of first reported transaction: sale of 20,000 common shares at a weighted average price of $20.0018. |
| 2024-09-24 | Date of second reported transaction: sale of 20,000 common shares at a weighted average price of $19.8231. |
| 2024-09-25 | Date of third reported transaction: sale of 20,000 common shares at a weighted average price of $19.8872. |
| 2024-09-25 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.